Abstract
HUS is a well-known entity primarily associated with bacterial infection and is characterized by a classic triad of anemia, thrombocytopenia, and kidney injury. Its atypical form has been associated with calcineurin inhibitors and has been extensively discussed in renal transplantation. We present a case of tacrolimus-associated HUS in a pediatric heart transplant recipient, which we believe to be previously unreported in the literature.
Original language | English (US) |
---|---|
Pages (from-to) | 866-867 |
Number of pages | 2 |
Journal | Pediatric transplantation |
Volume | 20 |
Issue number | 6 |
DOIs | |
State | Published - Sep 1 2016 |
Bibliographical note
Publisher Copyright:© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Keywords
- calcineurin inhibitors
- heart transplantation
- hemolytic uremic syndrome
- pediatrics